Get startedLog in
    Picture of Bristol-Myers Squibb Co logo

    BMY — Bristol-Myers Squibb Co News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareBalancedLarge CapSuper Stock
    All News

    Brief: Hengrui Pharma And Bristol Myers Squibb Announce Strategic Agreements To Advance Innovative Medicines

    Picture of Bristol-Myers Squibb Co logoBristol-Myers Squibb Co
    12/05/2026 05:28
    May 12 (Reuters) - Jiangsu Hengrui Pharmaceuticals Co Ltd 600276.SS:

HENGRUI PHARMA AND BRISTOL MYERS SQUIBB ANNOUNCE STRATEGIC AGREEMENTS TO ADVANCE INNOVATIVE MEDICINES ACROSS ONCOLOGY, HEMATOLOGY, AND IMMUNOLOGY

JIANGSU HENGRUI PHARMACEUTICALS CO LTD: UNDER TERMS OF AGREEMENT, BMS WILL PAY HENGRUI UP TO $950 MILLION

Source text: ID:nPn7CPp76a

Further company coverage: 600276.SS

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Bristol-Myers Squibb Co

    See all news